Prevention of hypervitaminosis A by spironolactone and anabolic steroids.
D000042:Absorption; D045930:Anabolic Agents / Q000494:pharmacology*; D000818:Animals; D001847:Bone Diseases / Q000517:prevention & control*; D001842:Bone and Bones / Q000032:analysis; D003900:Desoxycorticosterone / Q000494:pharmacology; D004336:Drug Antagonism; D004790:Enzyme Induction; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology*; D014221:Triamcinolone / Q000494:pharmacology; D014801:Vitamin A / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism
D045930:Anabolic Agents; D014801:Vitamin A; D014221:Triamcinolone; D013148:Spironolactone; D003900:Desoxycorticosterone; D011374:Progesterone; D004958:Estradiol